April 20, 2024: We’re presenting at SAPA 2024 Scientific Symposium, “Innovation with Versatility: New Approaches from Benchtop to Bedside“. Rutgers Robert Wood Johnson Medical School, Piscataway, NJ.
NanoBiotec and PicoImmune merged from Jan. 1, 2022, greatly strengthening our capabilities of ultra-sensitive and multiplex immunoassays and flow cytometric analysis to support our biopharma clients.
Welcome to our new lab. NanoBiotec moved into new labs in Dec. 2021 to expand our biopharma services to our clients. Our new address is 622 NJ-10, Suite 18, Whippany, NJ 07981.
NanoBiotec is rated as one of the TOP PERFORMERS in 2019. This was independently rated by fast-growing biotechs using Science Exchange, the world’s leading R&D marketplace, based on RESPONSIVENESS, PRODUCT-IVITY, POSITIVE CLIENT RECOMMENDATIONS. We are ranked as ” #3 for various biomarker, functional and cell-based assays”. (2019, Palo Alto, CA)
We are presenting in the Frontier in Cancer Immunotherapy, The New York Academy of Sciences, April 26, 2018, WTC, New York
Upcoming Events
2024 Advances in Cancer Immunotherapy™ series
2024 Annual Meeting of American Association of Immunologists (AAI)
2024 Annual Meeting of the Chinese Antibody Society (CAS)